Dechert Advises Aquestive Therapeutics on Pricing of $85MM Underwritten Offering of Common Stock
Dechert recently advised Aquestive Therapeutics on the pricing of an underwritten offering of 21,250,000 shares of its common stock at an offering price of $4.00 per share. The gross proceeds of the offering to Aquestive, before deducting the underwriting discounts...
Read moreDetails









